Re: Campochiaro et al.: The Port Delivery System with ranibizumab for neovascular age-related macular degeneration: results from the randomized phase 2 Ladder clinical trial (Ophthalmology. 2019;126:1141-1154)

Ophthalmology. 2019 Nov;126(11):e87-e88. doi: 10.1016/j.ophtha.2019.06.019.

¹ Department of Vitreoretina, Lotus Eye Hospital and Institute, Coimbatore, Tamilnadu, India. Electronic address: drashish79@hotmail.com.
² Department of Vitreoretina, Lotus Eye Hospital and Institute, Coimbatore, Tamilnadu, India.
³ Gavin Herbert Eye Institute, University of California, Irvine, Irvine, California.
⁴ Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milano, Italy.

No abstract available

Publication types